Home General Biotechnology Drug Patent Expirations in March 2013

Drug Patent Expirations in March 2013

Drug Patent Expirations for March 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
THALOMIDCelgenethalidomide8,143,283Mar 1, 2013
THALOMIDCelgenethalidomide7,723,361Mar 1, 2013
THALOMIDCelgenethalidomide6,235,756Mar 1, 2013
ZOMETANovartiszoledronic acid4,939,130*PEDMar 2, 2013
LUNESTASunovion Pharms Inceszopiclone6,864,257*PEDMar 2, 2013
RECLASTNovartiszoledronic acid4,939,130*PEDMar 2, 2013
NATROBAParapro Llcspinosad5,496,931Mar 5, 2013
FLO-PREDTaroprednisolone acetate6,102,254Mar 11, 2013
ABRAXANEAbraxis Biosciencepaclitaxel5,498,421Mar 12, 2013
COMBIVENT RESPIMATBoehringer Ingelheimalbuterol sulfate; ipratropium bromide5,497,944Mar 12, 2013
RYBIX ODTShionogi Inctramadol hydrochloride5,464,632Mar 22, 2013
XOPENEXSunovionlevalbuterol hydrochloride5,362,755Mar 25, 2013
XOPENEX HFASunovionlevalbuterol tartrate5,362,755Mar 25, 2013
SILENORSomaxondoxepin hydrochloride5,502,047Mar 26, 2013
LOVAZASmithkline Beechamomega-3-acid ethyl esters5,502,077Mar 26, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.